On the one hand, YAP can enhance the tumor proliferative transcriptional activity of mutant p53 (mtp53) protein (Di Agostino et al., 2016) through the ARF-NDM2-P53 INK4a-RB pathway, which has been defined as a significant approach of promoting oncogenic capacity. The gene discussed is CDKN2A; the disease is neoplasm.